
VTVT
Healthcare · Biotechnology · $79.0M market cap
$19.69-1.00 (-4.8%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -5.8% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -1.07 | -0.94 | +12.1% |
| Aug 6, 2026 | After the close | -0.75 | -1.05 | -40.0% |
| May 13, 2026 | After the close | 0.21 | 1.65 | +685.7% |
| Nov 6, 2025 | After the close | -0.98 | -1.08 | -10.2% |
| Aug 14, 2025 | After the close | -0.82 | -0.92 | -12.2% |
| May 15, 2025 | After the close | -0.73 | -0.77 | -5.5% |
| Mar 11, 2025 | Before the open | -0.87 | -0.55 | +36.6% |
| Nov 12, 2024 | After the close | -3.60 | -0.88 | +75.6% |
| Aug 8, 2024 | After the close | — | -0.81 | — |
| May 9, 2024 | After the close | — | -1.17 | — |
| Mar 13, 2024 | Before the open | -0.07 | -1.67 | -2285.7% |
| Nov 9, 2023 | After the close | -0.08 | -3.20 | -3900.0% |
| Aug 11, 2023 | After the close | -0.07 | -0.07 |
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing…
| 0.0% |
| May 11, 2023 | After the close | -0.09 | -0.06 | +33.3% |
| Mar 6, 2023 | After the close | -2.40 | -2.40 | 0.0% |
| Nov 10, 2022 | After the close | -1.80 | -2.00 | -11.1% |
| Aug 15, 2022 | After the close | -4.00 | -1.60 | +60.0% |
| May 12, 2022 | Before the open | -3.20 | -4.00 | -25.0% |
| Mar 29, 2022 | After the close | -0.07 | -0.11 | -57.1% |
| Nov 9, 2021 | Before the open | -2.80 | -0.80 | +71.4% |
| Aug 4, 2021 | After the close | -2.80 | -0.40 | +85.7% |
| May 5, 2021 | After the close | -2.40 | -3.20 | -33.3% |
| Feb 24, 2021 | After the close | -0.05 | 0.02 | +140.0% |
| Nov 5, 2020 | After the close | -4.20 | -1.20 | +71.4% |
| Aug 3, 2020 | After the close | -3.80 | -2.80 | +26.3% |
| May 7, 2020 | After the close | -4.00 | -4.40 | -10.0% |
| Feb 20, 2020 | After the close | -0.09 | -0.13 | -44.4% |
| Oct 30, 2019 | After the close | -6.40 | -7.42 | -15.9% |
| Jul 31, 2019 | After the close | -6.40 | -3.60 | +43.8% |
| May 1, 2019 | After the close | -0.24 | -0.09 | +62.5% |
| Feb 26, 2019 | After the close | -4.40 | -2.00 | +54.5% |
| Nov 8, 2018 | After the close | -4.80 | -2.40 | +50.0% |
| Aug 3, 2018 | Before the open | -16.00 | -12.40 | +22.5% |
| May 15, 2018 | After the close | -16.40 | -12.00 | +26.8% |
| Feb 27, 2018 | After the close | -16.60 | -17.60 | -6.0% |